Form D — Bambusa Therapeutics, Inc.
0002044950-25-000003 · filed Feb 26, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $88,879,860
- Total sold
- $53,267,941
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bambusa Therapeutics, Inc.
- CIK
- 2044950
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- ONE MARINA PARK DRIVE, SUITE 1410
BOSTON, MA 02210 - Phone
- 949-887-7927
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shanshan Xu · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Helmut Jeggle · DirectorBoston, MA Find on LinkedIn ↗
-
Sean Marett · DirectorBoston, MA Find on LinkedIn ↗
-
Derek DiRocco · DirectorBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗